Author:
Mashal Mohammed Taufiq,Eltayeb Dalya,Higgins-Steele Ariel,El Sheikh Ismael Suleiman,Abid Ni’ma Saeed,Shukla Hemant,Machado Leonard,Jafari Hamid
Abstract
Abstract
Background
During 2020 and immediately prior to the COVID-19 pandemic, Sudan was experiencing multiple emergencies including violence, seasonal flooding, and vector-borne disease outbreaks. After more than ten years since its last case of wild poliovirus, Sudan declared a circulating vaccine-derived poliovirus type 2 (cVDPV2) outbreak on 9 August 2020.
Methods
cVDPV2 outbreak response data and programme documents of the Federal Ministry of Health and WHO were reviewed. Surveillance data was verified through WHO-recommended procedures for detecting and characterizing polioviruses from stool and sewage samples collected from acute flaccid paralysis (AFP) cases and the environment.
Results
This outbreak in Sudan led to a total of 58 confirmed cases of cVDPV2 from 15 of the 18 states. Two nationwide vaccination campaigns were held to increase immunity of children under-five against poliovirus type 2. Funding challenges were overcome by intense additional resource mobilization from in-country sources. The funding gap was bridged from domestic resources (49%) sourced through GPEI partners, and in-country humanitarian funding mechanisms.
Conclusions
During an outbreak response and challenge of funding shortfall, mobilizing in-country resources is possible through coordinated approaches, regular communication with partners, disaggregation of needs, and matching in-kind and financial support to fill gaps. A cVDPV2 outbreak requires a fast, resourced, and quality response to stop virus circulation.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Thompson KM. Poliovirus vaccine options: another step forward. The Lancet. 2020;397:2–3.
2. Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(49):1691–9.
3. WHO. 14th meeting of the Global Commission for Certification of Poliomyelitis Eradication (GCC), Bali, Indonesia. Sept 20–21., 2015. Summary of findings, decisions and recommendations. https://polioeradication.org/wp-content/uploads/2016/07/1Report.pdf. Accessed 4 Sept 2022.
4. Hampton LM, Farrell M, Ramirez-Gonzalez A, et al. Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine— worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934–38.
5. Macklin GR, O’Reilly KM, Grassly NC, et al. Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine. Science. 2020;368:401–05.